Cardiorenal Debate. Scottish Heart Failure Nurse Forum September Dr Paddy Gibson. Dr Alan Japp. Consultant Cardiologist NHS Lothian
|
|
- Louisa Booker
- 5 years ago
- Views:
Transcription
1 Scottish Heart Failure Nurse Forum September 2017 Cardiorenal Debate { Dr Alan Japp Consultant Cardiologist NHS Lothian Vifor Pharma UK have sponsored this speakers for this presentation. Vifor Pharma have had no input into the content of the presentation, other than to check for compliance with industry codes of practice. Dr Paddy Gibson Consultant Nephrologist NHS Lothian
2 Understanding cardio-renal disease. Paddy Gibson Consultant Renal Physician Lothian
3 Save the lungs Sod the kidneys
4 Is this a problem? About 30% of patients with heart failure will have abnormal kidney function About 30% of patients undergoing treatment for heart failure will see a decline in their kidney function
5 Why?
6 Why?
7 Why? TYPE 2 DIABETES HYPERTENSION
8 Why? Heart failure leads to: Reduced cardiac output and poor renal perfusion Increased venous congestion, increased intrabdominal pressure and poor renal perfusion
9 Why? Heart failure leads to: Sympathetic activation and renal vasoconstriction causes poor renal perfusion Use of a lot of medicines that cause...poor renal perfusion
10 How does a kidney work?
11 And if it has to work harder...
12 In heart failure?
13 Add in medicines: ACEinhibitors Diuretics
14 So: The obvious thing to do is to stop ACEinhibitors & diuretics
15 What does the patient want? Probably to live a bit longer To stay out of hospital To not be breathless To be less afraid
16
17
18
19
20 So: Kidneys can cope with heart failure and the medicines you use People can withstand worse kidney function than you think You may need to use bigger diuretic doses than you re used to Fiddle with medicines rather than stop them And:
21 Save the lungs Sod the kidneys
22 Case 1: PC. 51 y/o male
23 Case 1: PC. 51 y/o male Admitted 3/3/15: Recent admission to RIE with abdo pain, SOB and deranged LFTs in context of longstanding alcohol excess Progressively worsening SOB with orthopnoea + PND Oedema and mild ascites; Atrial fibrillation AKI; mildly deranged LFTs Discharged on spiro 25 and furosemide 40; O/P echo Readmitted 9 days later after attending for echo
24 Case 1: PC Show echo
25 Case 1: PC On re-admission: SOB on any exertion; orthopnoea+++ JVP elevated +++ Peripheral oedema to thighs / groin At least mild ascites AF with rate ~110 BP 95/60 Worsening AKI since last discharge Compliant with spiro and furosemide
26 Case 1: PC Bloods (Day 3) 2 months ago 9 days ago Readmission day 1 Creatinine egfr > Urea K Qs 1. Continue, intensify or reduce diuretic treatment? 2. Any other treatments?
27 Case 1: PC Treatment: Furosemide 100mg IV bd Apixaban Digoxin Nothing else Next day.
28 Case 1: PC Bloods 2 months ago 9 days ago Readmission day 1 Creatinine egfr > Urea K Readmission day 2 Reports good diuresis; otherwise much the same Qs 1. Continue, intensify or reduce diuretic treatment?
29 Case 1: PC Prolonged admission (17 days) High dose IV diuretics AF rate control + anticoagulation Dramatic clinical improvement
30 Case 1: PC Bloods Readmission day 1 Readmission day 2 Readmission day 5 Creatinine egfr >60 Urea K Readmission day 15
31 Remember!
32 Remember! (Congestive kidney failure)
33 Case 1: PC Prolonged admission (17 days) High dose IV diuretics AF rate control + anticoagulation Dramatic clinical improvement Outpatient treatment: Apixaban 5mg bd, Furosemide 40mg daily Lisinopril 10mg daily, Bisoprolol 10mg daily Digoxin 125 migrograms daily, Spiro 25mg daily NYHA class 1; no further hospital admissions
34 Case 1: PC show echo
35 Case 2: HH. 73 y/o male GP Referral This 73 year old man has established cardiac failure, on a background of IHD with CABG, aortic valve replacement and AF. He also has CKD and typically runs an egfr in the low 30's. He presented recently with ankle swelling and SOB with signs of pulmonary oedema. His Furosemide was increased from 20mg to 40mg and his egfr fell to 21. The Furosemide was then reduced back to 20mg. In the past, there was a fall in his egfr on Lisinopril and it was stopped. His BP is also too high and I have increased his Doxazosin from 6mg to 8mg today. I would welcome advice on optimising his medication.
36 Case 2: HH. 73 y/o male Repeat Echocardiogram Normal LV size; mild to moderate LVH Abnormal septal motion (prev surgery) at worst mild LVSD Dilated left atrium Mild to moderate mitral regurgitation Aortic prosthesis well seated, satisfactory function RV normal size and function; Dilated right atrium TR velocity 2.6 cm/s
37 Case 2: HH. 73 y/o male Cardiologist response (not me) I suspect that the fundamental problem here is diastolic dysfunction which is also known as heart failure with a preserved ejection fraction. Hypertension, LVH and advancing years will all be contributing. The trick is to use the lowest possible dose of loop diuretic and treat the BP aggressively. I would maintain Frusemide 20 mg mane and try to bring the systolic pressure to 140 or less. Given the troublesome ankle swelling with Amlodipine I would try instead Lercanidipine 10 mg daily. If BP remains high or he has trouble with Lercanidipine then I would try Hydralazine 25 mg b.d., rechecking U+E after 1-2 weeks.
38 Case 2: HH. 73 y/o male Cardiologist response (not me) I suspect that the fundamental problem here is diastolic dysfunction which is also known as heart failure with a preserved ejection fraction. Hypertension, LVH and advancing years will all be contributing. The trick is to use the lowest possible dose of loop diuretic and treat the BP aggressively. I would maintain Frusemide 20 mg mane and try to bring the systolic pressure to 140 or less. Given the troublesome ankle swelling with Amlodipine I would try instead Lercanidipine 10 mg daily. If BP remains high or he has trouble with Lercanidipine then I would try Hydralazine 25 mg b.d., rechecking U+E after 1-2 weeks. Do you agree?
39 Case 2: HH. 73 y/o male My ward round (10 days later) Day 1 Background as detailed. Worsening SOB and ankle swelling for last month or so. Worsening renal function. Weight gain (14 kg). O/E: Hypertensive. AF with rate JVP up (6-7 cm). Bilat pitting oedema. HS1+2 + MR murmur at apex, TR murmur and soft early ESM aortic area. No diastolic murmurs. Imp: Combined heart failure (LVH, LVSD) and renal failure. Suspect recent deterioration in GFR due in part to renal congestion. Rate control excessive at the moment (both bisop and dig renally excreted) Plan:
40 Case 2: HH. 73 y/o male Chest X-Ray AKI on CKd,?any infection causing this, also CCF Report Comparison made with the previous x-ray dated 10 10/14. Central sternotomy wires and coronary clips. The heart is enlarged. Features of fluid overload with congested pulmonary vascularity, peribronchial cuffing and a new right pleural effusion.
41 Case 2: HH. 73 y/o male Bloods (Day 1) 2 weeks pre Day 1 Creatinine egfr Urea K Qs 1. What would you do with diuretic treatment? 2. Any other treatment changes?
42 Case 2: HH. 73 y/o male My ward round (10 days later) Day 1 Background as detailed. Worsening SOB and ankle swelling for last month or so. Worsening renal function. Weight gain (14 kg). O/E: Hypertensive. AF with rate JVP up (6-7 cm). Bilat pitting oedema. HS1+2 + MR murmur at apex, TR murmur and soft early ESM aortic area. No diastolic murmurs. Imp: Combined heart failure (LVH, LVSD) and renal failure. Suspect recent deterioration in GFR due in part to renal congestion. Rate control excessive at the moment (both bisop and dig renally excreted) Plan: Increase IV furosemide (50 bd to 80 bd). Fluid restrict L. Reduce dose bisop for now. Daily weights / U&E.
43 Case 2: HH. 73 y/o male US Kidneys worsening renal function (over months). proteinurea. Heart failure.?structural cause for decline in function/altered kidney size. Report Both kidneys are least 10 centimetres in length but diffuse parenchymal thinning to less than a centimetre and diffusely increased echotexture consistent with nonspecific nephropathic process. No mass or collecting system dilatation. Normal bladder. There is diffuse cardiomegaly. No pericardial collection. Distended hepatic veins and IVC.
44 Case 2: HH. 73 y/o male My ward round Day 3 Overall improvement but slower than expected progress and mild decline in egfr. P Hypertensive. Still quite significant residiual oedema and JVP remains up. Plan:
45 Case 2: HH. 73 y/o male Bloods (Day 3) 2 weeks pre Day 1 Day 2 Day 3 Creatinine egfr Urea K
46 Case 2: HH. 73 y/o male Bloods (Day 3) 2 weeks pre Day 1 Day 2 Day 3 Creatinine egfr Urea K Qs 1. Continue, intensify or reduce diuretic treatment? 2. Anything else to consider (renal or cardiac)?
47 Case 2: HH. 73 y/o male My ward round Day 3 Overall improvement but slower than expected progress and mild decline in egfr. P Hypertensive. Still quite significant residual oedema and JVP remains up. Plan: Keep in over weekend. Repeat U+E Sunday. Echo today. Increase furosemide slightly. Continue to withhold dig. Add ISMN. Hopefully home start of next week.
48 Case 2: HH. 73 y/o male Weekend ward round Day 5 BG Hx noted: 1. Combined heart failure (LVH, LVSD) and renal failure Renal func remains poor Urea:14.7 (15) Creat 322 (312) egfr: 16 (17) P: 1. R/v mane by Cardio
49 Case 2: HH. 73 y/o male Bloods (Day 5) 2 weeks pre Day 1 Day 2 Day 3 Day5 Creatinine egfr Urea K
50 Case 2: HH. 73 y/o male My ward round Day 6 Feeling better. Weight down. Still has significant residual oedema but JVP now only marginally elevated. HS unchanged. Further slide in renal function. HR now ~70 (AF) Plan: IV to oral diuretics. Stay off dig in view of GFR. Increase ISMN; stop doxazosin. Echo and bloods tmrw then home tmrw afternoon with F/U in MDU. NB: discharged on oral Furosemide 80 mg bd.
51 Case 2: HH. 73 y/o male MDU review (junior doc attached to cardio) 1 week later appears symptomatically well. His ET is almost back to baseline, and he reports no orthopnoea and no PND. His peripheral oedema continues to improve. His weight continues to decrease, and today is 94.1kg (was >100kg on admission). HR is 69 and BP is 181/84. Sats 96% on room air. He has a visible JVP which is slightly elevated, he has quiet bibasal creps,. He has peripheral oedema to his mid shin which is much improved since admission. Bloods show egfr of 15, creatinine of 345 (from 322). His renal function has slowly been creeping down over the past 2 weeks in the context of high dose diuretics.
52 Case 2: HH. 73 y/o male Bloods (Day 2) 2 weeks pre Day 1 Day 2 Day5 1 week later Creatinine egfr Urea K
53 Case 2: HH. 73 y/o male MDU review (junior doc attached to cardio) 1 week later continued Overall, I think Mr H's heart failure is improving, and I think his renal function may be contributing to his peripheral congestion. I have decreased his furosemide to 80mg/40mg and asked him to get his renal function rechecked in 1 weeks time to ensure his renal function is improving. He has follow up with renal team on 18/5/17.
54 Case 2: HH. 73 y/o male MDU review (junior doc attached to cardio) 1 week later continued Overall, I think Mr H's heart failure is improving, and I think his renal function may be contributing to his peripheral congestion. I have decreased his furosemide to 80mg/40mg and asked him to get his renal function rechecked in 1 weeks time to ensure his renal function is improving. He has follow up with renal team on 18/5/17. Do you agree?
55 Case 2: HH. 73 y/o male MDU review (junior doc attached to cardio) 1 week later continued Overall, I think Mr H's heart failure is improving, and I think his renal function may be contributing to his peripheral congestion. I have decreased his furosemide to 80mg/40mg and asked him to get his renal function rechecked in 1 weeks time to ensure his renal function is improving. He has follow up with renal team on 18/5/17. Paddy, do you agree?
56 Case 2: HH. 73 y/o male No
57 Case 2: HH. 73 y/o male Paddy Gibson clinic letter The priority for Mr H is going to be keeping him clear of fluid. It will be his tendency to fluid overload and pulmonary oedema that causes him to be admitted to hospital.
58 Case 2: HH. 73 y/o male Paddy Gibson clinic letter The priority for Mr H is going to be keeping him clear of fluid. It will be his tendency to fluid overload and pulmonary oedema that causes him to be admitted to hospital. I think his clinical condition will not be influenced all that much by his biochemistry and I would be cautious in making reductions in his diuretic dose because of impaired biochemistry.
59 Case 2: HH. 73 y/o male Paddy Gibson clinic letter The priority for Mr H is going to be keeping him clear of fluid. It will be his tendency to fluid overload and pulmonary oedema that causes him to be admitted to hospital. I think his clinical condition will not be influenced all that much by his biochemistry and I would be cautious in making reductions in his diuretic dose because of impaired biochemistry. I think it is likely that there is a Furosemide dose that keeps him free of fluid with stable biochemistry and once this dose is achieved it should be maintained.
60 Case 2: HH. 73 y/o male 7 weeks later.. My clinic CURRENT MEDICATIONS: Furosemide 80 mg am; 40 mg lunchtime Folic acid 5 mg o.d. Isosorbide mononitrate 60 mg b.d. Atorvastatin 10 mg nocte Bisoprolol 5mg Warfarin as per INR MEDICATION CHANGES:? I reviewed Mr. H in Dr. Japp's clinic today. Since discharge his SOB has continued. A CXR in mid July showed pulmonary congestion. There was evidence of this today with an elevated JVP, bilateral pitting oedema to knees and crackles to the mid zones. He describes 3 pillow orthopnoea but no PND.
61 Case 2: HH. 73 y/o male 7 weeks later.. My clinic CURRENT MEDICATIONS: Furosemide 80 mg am; 40 mg lunchtime Folic acid 5 mg o.d. Isosorbide mononitrate 60 mg b.d. Atorvastatin 10 mg nocte Bisoprolol 5mg Warfarin as per INR MEDICATION CHANGES: Increase Frusemide today to 120 mg mane, 80 mg at lunchtime. For review by GP in 2 to 3 weeks' time and increase to 120 mg b.d. if required Review rate - consider increase Bisoprolol to 7.5 mg o.d.
62 Case 3: EG. 69 y/o female Cardiology referral letter Mrs G was referred to my clinic for syncope during exercise but at the same time she had developed nephrotic syndrome with Bence Jones protein.the syncope tends to happen after strenuous exercise or more specifically during it. The echo shows a small LV cavity with moderate concentric left ventricular hypertrophy. The patient is only 69 and has not got any ischaemic heart disease. I wonder if this finding is significant.
63 Case 3: EG. 69 y/o female Cardiology (not me): There is mild LVH on echocardiogram with septal thickness of 17 mm. The aortic valve is bicuspid but there is no stenosis. I note that she is being referred elsewhere because of proteinuria. I do not think that the clinical picture is consistent with hypertrophic cardiomyopathy but I will arrange both a cardiac MRI scan and a 24-hour ambulatory blood pressure profile before writing again.
64 Case 3: EG. 69 y/o female Other symptoms: 1. bilateral feet pains which are of an unusual character 2. some back pain
65 Show echo / MRI Case 3: EG. 69 y/o female
66 Case 3: EG. 69 y/o female Last Review (Haematology Outpatients) DIAGNOSES: 1. AL Amyloidosis with cardiac and renal involvement 2. Low level plasma cell dyscrasia - less than 10% in bone marrow at baseline 3. Completed 5 cycles of VCD chemotherapy This lady returned for further assessment in the Haematology clinic accompanied by her daughter. She has now completed 5 cycles of chemotherapy which she has tolerated extraordinarily well. Having said that she continues to have a sensory polyneuropathy being troubled by neuropathic pain and paraesthesia in her hands and feet.
67 Thank you
Cardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care
Cardiology Presented by: Dr Paul Bethell GP Lead for Planned Care 16 th April 2015 Integrated Cardiology Service for Ipswich and East Suffolk CCG IHT 6 consultants - all with specialist areas PCI CoW rapid
More informationCharles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT
Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis
More information8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)
Professor Ralph Stewart Cardiologist Auckland City Hospital Green Lane Cardiovascular Research Unit Auckland Heart Group Fiona Stewart Cardiologist Green Lane Hospital National Women's Hospital Professor
More informationAdvanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary
Advanced Heart Failure Management Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Grading of heart failure Mr WY age 73 3/12 dyspnoea, fatigue and some ankle oedema PMH: hypertension
More informationMore acute cardiology
Case 1 RC 86, Male More acute cardiology Dr John Chambers Consultant Cardiologist A&E: SOB at rest. No chest pain. Exertional SOB for 6/12. PMHx: HT Rx: Ramipril 5mg od Examination: Afebrile, HR = 105,
More informationHeart Failure from a GP perspective
Heart Failure from a GP perspective Jane Gilmour, Alison Wright Clinical Nurse Specialists for Heart Failure The Heart failure Team Dr Ganesan Kumar- Consultant Cardiologist Dr D Maras- Staff Grade Cardiology
More informationHEART FAILURE. Study day November 2018 Sarah Briggs
HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure
More informationEvaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography
Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods
More informationPresentation, symptoms and signs of heart failure
3 Presentation, symptoms and signs of heart failure What will I learn? In this section you will learn: Who is at risk of heart failure The symptoms of heart failure The signs of heart failure The importance
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationThe Causes of Heart Failure
The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions
More informationARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:
ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to
More informationSONOGRAPHER & NURSE LED VALVE CLINICS
SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationHeart Failure A Disease for the Internist?
Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices
More informationHeart Valve disease: MR. AS tough patient When to echo, When to refer, What s new
Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new B. Sonnenberg UAH Cardiology CME Day 5 May 2015 Disclosures Speaker s or Advisory Boards: none Research grants: none (co-investigator
More informationBSH Heart Failure Day for Revalidation and Training 2017
BSH Heart Failure Day for Revalidation and Training 2017 Presentation title: Case Presentation cardio-oncology Speaker: Mark Drury-Smith Conflicts of interest: None British Society of Heart Failure 2017
More information1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?
1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist
More informationLIVING WITH HEART FAILURE
1 PERSONAL RECORD An everyday guide to LIVING WITH HEART FAILURE Personal record HOW TO USE THIS RECORD This personal record accompanies our publication An everyday guide to living with heart failure.
More informationCase Summary. Workshop Overview. Mr. M
9:00 10:30 Workshop Overview Mr. M Who is this document primarily intended to reach? What is the format? How soon should I see a newly referred heart failure patient? How often should my heart failure
More informationMarch yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months
Case 1 March 2016 59 yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months PMH diabetes, celiac disease Reports chest discomfort, positional coughing and pedal edema last 10
More informationNT-proBNP: Evidence-based application in primary care
NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationWHAT IS CONGESTIVE HEART FAILURE?
WHAT IS CONGESTIVE HEART FAILURE? Congestive heart failure (CHF) is a term used to describe the heart s inability to pump enough blood to meet the body s needs. Heart failure does not mean that the heart
More informationAn everyday guide to. living with heart failure: Personal record
An everyday guide to living with heart failure: Personal record Contact details How to use this record Your details Name of birth Phone Hospital details Hospital consultant GP details GP Phone Address
More informationUpdate on Palpitations and AF February 28 th 2018
Update on Palpitations and AF February 28 th 2018 Dr Mrinal Andrew Saha MA(Cantab) MBBS FRCP PhD Consultant Interventional Cardiologist GHNHSFT Dr Mrinal Saha Appointed 2010 Special interests: Angioplasty,
More informationSusan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
More informationHeart Failure Dr ahmed almutairi Assistant professor internal medicin dept
Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF
More informationCongenital Heart Disease Cases
Congenital Heart Disease Cases Sabrina Phillips, MD FACC FASE Mayo Clinic Congenital Heart Disease Center 2013 MFMER slide-1 No Disclosures 2013 MFMER slide-2 1 CASE 1 2013 MFMER slide-3 63 year old Woman
More informationValvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust
Valvular Heart Disease: Assessment and Timing of Intervention Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust Disclosures: Speaker fee: Bayer Acknowledgements: Matt Shun-Shin
More informationPericardial Disease: Case Examples. Echo Fiesta 2017
Pericardial Disease: Case Examples Echo Fiesta 2017 2014 2014 MFMER MFMER 3346252-1 slide-1 Objectives Have a systematic approach to evaluation of constriction 2014 MFMER 3346252-2 CASE 1 2013 MFMER 3248567-3
More informationCase 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?
Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising
More informationA patient with acute heart failure and renal impairment ACCA Masterclass 2017
A patient with acute heart failure and renal impairment Dr Sofie Gevaert Mister P. J.M., 67-years-old Cardiac risk factors: Ex-smoker, AHT, Type 2 diabetes, BMI 43, Hyperlipidaemia Medical history: 2009:
More informationHeart-failure or Kidney Failure?
Heart-failure or Kidney Failure? Dr Ajith James Consultant Nephrologist Barts Health and BHRUT Mr AR 65 yrs Case Type 2 DM, IHD-MI 1998, 2003. PCI x 3. CABG 2008, HT CCF with LVEF 30% 2014. NYHA Class
More informationARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM
ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record
More informationRadiology of the respiratory/cardiac diseases (part 2)
Cardiology Cycle - Lecture 6 436 Teams Radiology of the respiratory/cardiac diseases (part 2) Objectives Done By Team Leaders: Khalid Alshehri Hanin Bashaikh Team Members: Leena Alwakeel Aroob Alhuthail
More informationProtocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year
PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart
More informationThe Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician
The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has
More informationChoose the grading of diastolic function in 82 yo woman
Question #1 Choose the grading of diastolic function in 82 yo woman E= 80 cm/s A= 70 cm/s LAVI < 34 ml/m 2 1= Grade 1 2= Grade 2 3= Grade 3 4= Normal 5= Indeterminate 2018 MFMER 3712003-1 Choose the grading
More informationSandwell Community Heart Failure Team. Community Heart failure Specialist Nurses: Hilda O Keeffe- Henry and Jacqui Elson-Whittaker
Sandwell Community Heart Failure Team Community Heart failure Specialist Nurses: Hilda O Keeffe- Henry and Jacqui Elson-Whittaker NICE 2010 Incidence and Prevalence 900,000 people in the UK with HF Same
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationLooking Outside the Box: Incidental Extracardiac Finding in Echo
Looking Outside the Box: Incidental Extracardiac Finding in Echo Dr. Aijaz Shah Head of Division, Adult Echocardiography Laboratory Prince Sultan Cardiac Centre Riyadh Case 1 17 year old boy presented
More informationTips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance
Tips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance J. Parissis Attikon University Hospital, Athens, Greece Disclosures ALARM investigator received
More informationHEART FAILURE. Ali Mehr, MD, FACC
HEART FAILURE Ali Mehr, MD, FACC Advanced Heart Failure and Transplant Cardiologist Director, Echocardiography Lab Phoenix VA Health Care System Associate Professor of Medicine University of Arizona, COM,
More informationDr Emma Copsey Consultant Cardiologist Glenfield Hospital 28 th September 2017
Dr Emma Copsey Consultant Cardiologist Glenfield Hospital 28 th September 2017 Educational Objectives Objectives To review the GIM & Cardiology syllabus for HF To review the new nomenclature/classification
More informationAtrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency
Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationDiastolic Heart Function: Applying the New Guidelines Case Studies
Diastolic Heart Function: Applying the New Guidelines Case Studies Mitral Regurgitation The New ASE William Guidelines: A. Zoghbi Role MD, of FASE, 2D/3D MACCand CMR Professor and Chairman, Department
More informationNew Therapies for the Heart Patient. Wilson They said "There's nothing more that can be done." Robert Federici MD, Presbyterian Heart
New Therapies for the Heart Patient Wilson 2016 They said "There's nothing more that can be done." Robert Federici MD, Presbyterian Heart Disclosure Boston Scientific Physician Proctor for CTO's, Clinical
More informationMedical Apps for Cardiology Uses. There s an App for That!
Medical Apps for Cardiology Uses There s an App for That! Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated
More informationHeart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHeart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationCongestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption
Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty
More informationPeripartum Cardiomyopathy. Lavanya Rai Manipal
Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting
More informationEchocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction
Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none
More informationPharmaceutical Care of People with Atrial Fibrillation. Course activities
Pharmaceutical Care of People with Atrial Fibrillation Course activities Pharmaceutical Care of People with Atrial Fibrillation Course activities page 3 Case Study 1 5 Case Study 2 7 Case Study 3 9 Case
More informationAccurately Diagnosing and Coding Heart Failure. Dr XXXXXXX Consultant Cardiologist
Accurately Diagnosing and Coding Heart Failure Dr XXXXXXX Consultant Cardiologist Clinical Signs of Heart Failure Diagnosis of Heart failure (ESC guidelines 2012) The diagnosis of heart failure with reduced
More informationACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST
ACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST AIMS & OBJECTIVES Review the functions of the kidney Identify renal
More informationAn Update in Heart Failure
An Update in Heart Failure Dr Peter Dias Cardiologist Heartswest AHFCTS Fiona Stanley Hospital Disclosures No financial, industry, pharma disclosures I am not an endocrinologist References Heart disease
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationAdvanced Pathophysiology Unit 5 CV Page 1 of 24. Learning Objectives:
Advanced Pathophysiology Unit 5 CV Page 1 of 24 Learning Objectives: 1) What is the definition of HF? How can we get it? Is it just the failing heart? 2) AHA/ACC stages of HF compared to older NYHA classes
More informationOn Referral to our Unit
Case Presentation By Samah Ibrahim Abdel Meguid Idris, MD Internal Medicine & Nephrology Consultant Head of Hemodialysis Unit Ahmed Maher Hospital, Alexandria Patient Data MEA 27-year-old male patient
More informationHeart Valves: Before and after surgery
Heart Valves: Before and after surgery Tim Sutton, Consultant Cardiologist Middlemore Hospital, Auckland Auckland Heart Group Indications for intervention in Valvular disease To prevent sudden death and
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationThe new Guidelines: Focus on Chronic Heart Failure
The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal
More informationYear 1 Peer Based Learning 2018 Renal System
Please note this learning resource has been produced by the GUMS Academic Team. It is possible that there are some minor errors in the questions/answers, and other possible answers that are not included
More informationWhat Is Valvular Heart Disease? Heart valve disease occurs when your heart's valves do not work the way they should.
What Is Valvular Heart Disease? Heart valve disease occurs when your heart's valves do not work the way they should. How Do Heart Valves Work? MAINTAIN ONE-WAY BLOOD FLOW THROUGH YOUR HEART The four heart
More informationDr Dinna Soon. Consultant Cardiologist, Department of Cardiology. GP symposium 2 April 2016
Dr Dinna Soon Consultant Cardiologist, Department of Cardiology GP symposium 2 April 2016 Case presentation 76 years old male, chronic smoker, hypertension, previous MI 3/7 SOB and chest tightness BP
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers MANAGEMENT
More informationNo Catheter, No CAUTI Scenario 1 Urinary catheter-trauma
No Catheter, No CAUTI Scenario 1 Urinary catheter-trauma Course lead Colette Laws-Chapman Faculty Course / Curriculum Scenario name No Catheter, No catheter associated urine infection (CAUTI) Scenario
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationThe right heart: the Cinderella of heart failure
The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart
More informationSevere Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes
Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.
More informationAtrial Fibrillation and Heart failure
Atrial Fibrillation and Heart failure and a bit about anticoagulation Tim Sutton, Consultant Cardiologist Middlemore Hospital, Manukau City and Auckland Heart Group Why Does AF Cause Heart Failure Impaired
More informationPulmonary Hypertension: Another Use for Viagra
Pulmonary Hypertension: Another Use for Viagra Kathleen Tong, MD Director, Heart Failure Program Assistant Clinical Professor University of California, Davis Disclosures I have no financial conflicts A
More informationAdel Hasanin Ahmed 1
Adel Hasanin Ahmed 1 PERICARDIAL DISEASE The pericardial effusion ends anteriorly to the descending aorta and is best visualised in the PLAX. PSAX is actually very useful sometimes for looking at posterior
More informationECG Workshop. Nezar Amir
ECG Workshop Nezar Amir Myocardial Ischemia ECG Infarct ECG in STEMI is dynamic & evolving Common causes of ST shift Infarct Localisation Left main artery occlusion: o diffuse ST-depression with ST elevation
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Heart Failure Heart Failure Introduction and History AHA 2015 Statistics About 6 million Americans 870,000 new cases each year 1 in 9 deaths related to HF Almost 1 million hospitalizations each year (cost
More informationConflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016
Conflict Disclosures Vermont Cardiac Network The Speaker has reported no significant financial relationship with any companies whose product may be germane to the content of their presentations or who
More informationCASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG
CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery
More informationHeart Failure. GP Update Refresher 18 th January 2018
GP Update Refresher 18 th January 2018 Heart Failure Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British
More informationDiagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta
Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations
More informationUltra-Portable Ultrasound in the Critical Care Unit
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/advances-in-medical-imaging/ultra-portable-ultrasound-in-the-criticalcare-unit/3632/
More informationChronic renal failure
Chronic renal failure Dr. Alexander Woywodt Consultant Physician and Nephrologist / Hon. Senior Lecturer Lancashire Teaching Hospitals NHS Foundation Trust Fleetwood 23rd June 2009 Menu Epidemiology &
More informationNavigating the identification, diagnosis and management of pulmonary hypertension using the updated ESC/ERS guidelines
Navigating the identification, diagnosis and management of pulmonary hypertension using the updated ESC/ERS guidelines Host: Marc Humbert Speaker: Simon Gibbs Marc HUMBERT, MD, PhD Professor of Respiratory
More informationHEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing
HEART FAILURE Study day November 2017 Sarah Briggs and Janet Laing Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology
More informationHeart Failure in the Elderly
This Presentation Heart Failure in the Elderly Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS Heart Failure Statistics Causes of Heart Failure Signs and Symptoms of Heart Failure Treatment
More informationCentral Sleep Apnea Problem Based Learning Module
Central Sleep Apnea Problem Based Learning Module Vidya Krishnan, and Sutapa Mukherjee for the Sleep Education for Pulmonary Fellows and Practitioners, SRN ATS Committee 2015 Case Section I A 75 year old
More informationDAY1_CARDIOVASCULAR PRACTICE QUESTIONS
DAY1_CARDIOVASCULAR PRACTICE QUESTIONS 1 P age 1. A 59-year-old male is admitted complaining of chest pain and dyspnea. ST elevation and T-wave inversion were seen on the ECG in V2, V3, and V4. IV thrombolytic
More informationInverclyde CHP Protected Learning Event- Heart Failure
Inverclyde CHP Protected Learning Event- Heart Failure 14:00 14:05 14:05 14:20 14:20 14:30 14:30 15:10 15:10 15:30 15:30 15:50 15:50 16:05 16:05 16:35 Welcome & Introduction Paul Forsyth (HF Pharmacist)
More informationWednesday September 20 th CMT Regional Study Day. Dr Colin Mason, Consultant DME, Addenbrooke s Hospital
Wednesday September 20 th CMT Regional Study Day Dr Colin Mason, Consultant DME, Addenbrooke s Hospital Develop a structured approach to a patient presenting with a fall Risk stratify who can go home and
More informationNHS GRAMPIAN MEDICAL TREATMENT GUIDELINES FOR CHRONIC HEART FAILURE (CHF) DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
NHS GRAMPIAN MEDICAL TREATMENT GUIDELINES FOR CHRONIC HEART FAILURE (CHF) DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD) MANAGED CLINICAL NETWORK FOR CHRONIC HEART FAILURE November 2006 Review date:
More informationPresenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center
Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationALLHAT. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute
U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Review of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment
More information